A New Viewpoint: Dr. Sclafani’s Take on Screen Time – Part 2

a-new-viewpoint-dr-sclafanis-take-on-screen-time-part-2.jpga-new-viewpoint-dr-sclafanis-take-on-screen-time-part-2.jpgThrough years of practice and motherhood, Louise Sclafani, OD, FAAO, FSLS, has seen the impact that screen time can have on children. Though she recognizes that the amount of time spent with digital devices is unlikely to drop any time soon, she also knows that there are ways to help protect young eyes. Dr. Sclafani has a solution for parents that offers protection through nutrition: EyePromise®Screen Shield™ Teen.

How Do You Think Patients Will React to This Vitamin?

I think, in general, people like to be proactive about their health, and parents want to be even more proactive about their kids’ health. Parents are very aware of the detriments of UV lights on other aspects of the eye, and they’re becoming more aware of the inherent damage that can be caused by digital screens. Blue light from screens is an artificial UV element we haven’t encountered in the past, and nobody looks at the sun for six hours, yet kids are on devices for six or more hours a day! We can’t get kids off their screens, but we can be proactive and give them supplements that protect against UV light.

What Do You Think Kids Will Think?

When I talked to my son about it, I was surprised that he saw the potential benefits of a vitamin that protects kids’ eyes from screens. He thinks it’s smart because everything at school is done online.

Would You Recommend Suggesting This Vitamin to All Children and Teens?

a-new-viewpoint-dr-sclafanis-take-on-screen-time-part-2.png

I don’t see a reason why all kids couldn’t use it, but I think I’m going to really focus on the ones who come in and can’t or won’t get off their phones when they are in my exam room.

Screen Shield Teen & Your Practice

In the next post, Dr. Sclafani explains how she will utilize this information and EyePromise Screen Shield Teen in her daily practice.

https://www.lvcenter4sight.com/a-new-viewpoint-dr-sclafanis-take-on-screen-time-part-2/

Comments

Post a Comment

Popular posts from this blog

Week in review: Pay raise, Von’s Vision, gonio-<em>what?</em>

Image
APR 13, 2018 By Anni Griswold Comprehensive Ophthalmology, Cornea/External Disease, Glaucoma, Pediatric Ophth/Strabismus Above: The GonioPEN (Credit: Nanyang Technological University) A weekly roundup of ophthalmic news from around the web. Ophthalmologists earn more than the average physician , and their salaries are on the rise (+3% over the last year, to be precise). Eye docs will earn a mean $375,000 this year—more than the physician average of $299,000, but well below a typical plastic surgeon’s paycheck. See for yourself in Medscape’s 2018 Physician Compensation Report . Medscape A special supplement to USA Today will highlight the work of Von Miller , a 28-year-old linebacker for the Denver Broncos and former Super Bowl MVP. Through his foundation, Von’s Vision, Miller connects thousands of underprivileged children in Denver with affordable, high-quality eye care. His interview will appear in the “Vision Health” campaign during World Glaucoma Week, available in pr...
Read more

Patch with Microneedles Could Replace Eye Injections

Image
Instead of getting eye injections, patients with serious eye diseases may be eligible for a contact lens-type patch. 1 Injections are often recommended for eye diseases such as Wet (advanced) Age-Related Macular Degeneration, macular edema, and glaucoma. The new patch is inserted painlessly like a contact lens. It delivers tiny microneedles containing medication. The microneedles are made from natural materials and dissolve over time, gradually releasing medicine. Patients would be more likely to stick with a regimen that does not involve eye injections. Eye Injections: Stick a Needle in My Eye Patients generally dread eye injections. Injections must be performed in a doctor’s office. Eye injections can be painful, and they are inconvenient. They can introduce infection. And they can damage the eye. Avastin, Eylea, and Lucentis are injectable medications that discourage new blood vessel growth. These anti-VEGF medicines are useful for advanced Macular Degeneration , Diabetic Retino...
Read more

Lacrimal intubation improves optical quality in patients with epiphora

JAN 19, 2018 The first prospective study to evaluate the visual function and optical quality in patients with epiphora before and after lacrimal surgery. Study design This prospective study investigated functional visual acuity, higher order aberrations, lower tear meniscus and tear clearance in 30 patients (34 eyes) who underwent lacrimal passage intubation by a single surgeon. All patients had a canalicular obstruction, nasolacrimal duct obstruction or partial nasolacrimal duct obstruction. Outcomes Investigators observed significant improvements in visual function as shown by improved functional visual acuity and visual maintenance ratio. There was a significant decrease in tear meniscus dimension, which correlated with decreased blinking frequency. Optical quality significantly improved as indicated by a decrease in coma-like aberrations, spherical-like aberrations and total higher order aberrations. Stability index increased and fluctuation index decreased. Limitatio...
Read more